相似文献
1
Broth microdilution susceptibility testing of Brucella species: quality control limits for ten antimicrobial agents against three standard quality control strains.
J Clin Microbiol. 2005 Nov;43(11):5804-7. doi: 10.1128/JCM.43.11.5804-5807.2005.
2
Broth microdilution susceptibility testing of Francisella tularensis: quality control limits for nine antimicrobial agents and three standard quality control strains.
J Clin Microbiol. 2004 Dec;42(12):5877-80. doi: 10.1128/JCM.42.12.5877-5880.2004.
3
In vitro antimicrobial susceptibility of Brucella species.
Int J Antimicrob Agents. 2004 Apr;23(4):405-7. doi: 10.1016/j.ijantimicag.2003.09.024.
4
Lack of effective bactericidal activity of new quinolones against Brucella spp.
Antimicrob Agents Chemother. 1991 Apr;35(4):756-9. doi: 10.1128/AAC.35.4.756.
5
Effect of carbon dioxide on broth microdilution susceptibility testing of Brucella spp.
J Clin Microbiol. 2010 Mar;48(3):952-6. doi: 10.1128/JCM.01860-09. Epub 2009 Dec 23.
6
Effect of antibiotics contained in two Brucella selective media on growth of Brucella abortus, B. melitensis, and B. ovis.
J Clin Microbiol. 1996 Feb;34(2):426-8. doi: 10.1128/jcm.34.2.426-428.1996.
7
Broth microdilution susceptibility testing of Campylobacter jejuni and the determination of quality control ranges for fourteen antimicrobial agents.
J Clin Microbiol. 2005 Dec;43(12):6136-8. doi: 10.1128/JCM.43.12.6136-6138.2005.
8
Development of a selective culture medium for primary isolation of the main Brucella species.
J Clin Microbiol. 2011 Apr;49(4):1458-63. doi: 10.1128/JCM.02301-10. Epub 2011 Jan 26.
9
Quality control limits for dilution and disk diffusion susceptibility tests of trovafloxacin against eight quality control strains.
J Clin Microbiol. 1998 Feb;36(2):585-6. doi: 10.1128/JCM.36.2.585-586.1998.
10
Spectrum of activity, mutation rates, synergistic interactions, and the effects of pH and serum proteins for fusidic acid (CEM-102).
Diagn Microbiol Infect Dis. 2010 Mar;66(3):301-7. doi: 10.1016/j.diagmicrobio.2009.10.014.
引用本文的文献
1
Adaptation of Antimicrobial Susceptibility Testing to the ISO 20776 Standard and Validation of the Method.
Microorganisms. 2022 Jul 20;10(7):1470. doi: 10.3390/microorganisms10071470.
2
Antimicrobial Resistance in , , and Other Rarely Investigated Veterinary and Zoonotic Pathogens.
Microbiol Spectr. 2018 Jul;6(4). doi: 10.1128/microbiolspec.ARBA-0029-2017.
3
Effect of carbon dioxide on broth microdilution susceptibility testing of Brucella spp.
J Clin Microbiol. 2010 Mar;48(3):952-6. doi: 10.1128/JCM.01860-09. Epub 2009 Dec 23.
4
Statistical methods for establishing quality control ranges for antibacterial agents in Clinical and Laboratory Standards Institute susceptibility testing.
Antimicrob Agents Chemother. 2007 Jul;51(7):2483-8. doi: 10.1128/AAC.01457-06. Epub 2007 Apr 16.
本文引用的文献
1
Brucellosis.
Int J Antimicrob Agents. 1995 Jul;5(4):203-8. doi: 10.1016/0924-8579(95)00003-q.
2
Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis.
Scand J Infect Dis. 2004;36(9):636-8. doi: 10.1080/00365540410020767.
3
The microbiology laboratory's role in response to bioterrorism.
Arch Pathol Lab Med. 2002 Mar;126(3):291-4. doi: 10.5858/2002-126-0291-TMLSRI.
4
Recommendations for susceptibility tests on fastidious organisms and those requiring special handling.
J Antimicrob Chemother. 2001 Jul;48 Suppl 1:77-80. doi: 10.1093/jac/48.suppl_1.77.
5
In vitro activities of six new fluoroquinolones against Brucella melitensis.
Antimicrob Agents Chemother. 1999 Jan;43(1):194-5. doi: 10.1128/AAC.43.1.194.
6
Open, randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucellosis.
Clin Infect Dis. 1993 May;16(5):671-6. doi: 10.1093/clind/16.5.671.
7
In vitro activities of new macrolides and rifapentine against Brucella spp.
Antimicrob Agents Chemother. 1993 Apr;37(4):911-3. doi: 10.1128/AAC.37.4.911.
8
In vitro susceptibility of Brucella to various antibiotics.
Appl Microbiol. 1970 Oct;20(4):600-4. doi: 10.1128/am.20.4.600-604.1970.
9
Antimicrobial susceptibility of clinical isolates of Brucella.
Diagn Microbiol Infect Dis. 1986 Jul;5(2):163-9. doi: 10.1016/0732-8893(86)90118-5.
10
Comparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin, and other selected antimicrobial agents against Brucella melitensis.
Antimicrob Agents Chemother. 1989 Aug;33(8):1409-10. doi: 10.1128/AAC.33.8.1409.
Zotero 插件